Jackevicius C - Search Results

1

CCORT/CCS quality indicators for acute myocardial infarction care.

Tran CT, Lee DS, Flintoft VF, Higginson L, Grant FC, Tu JV, Cox J, Holder D, Jackevicius C, Pilote L, Tanser P, Thompson C, Tsoi E, Warnica W, Wielgosz A; Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society; Acute Myocardial Infarction Quality Indicator Panel. Tran CT, et al. Among authors: jackevicius c. Can J Cardiol. 2003 Jan;19(1):38-45. Can J Cardiol. 2003. PMID: 12571693

2

Use of the statins in patients after acute myocardial infarction: does evidence change practice?

Jackevicius CA, Anderson GM, Leiter L, Tu JV. Jackevicius CA, et al. Arch Intern Med. 2001 Jan 22;161(2):183-8. doi: 10.1001/archinte.161.2.183. Arch Intern Med. 2001. PMID: 11176731

3

Adherence with statin therapy in elderly patients with and without acute coronary syndromes.

Jackevicius CA, Mamdani M, Tu JV. Jackevicius CA, et al. JAMA. 2002 Jul 24-31;288(4):462-7. doi: 10.1001/jama.288.4.462. JAMA. 2002. PMID: 12132976

4

Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001.

Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Jackevicius CA, et al. Can J Cardiol. 2003 Nov;19(12):1359-66. Can J Cardiol. 2003. PMID: 14631469

5

Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.

Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team. Pilote L, et al. Among authors: jackevicius c. Can J Cardiol. 2004 Jan;20(1):61-7. Can J Cardiol. 2004. PMID: 14968144

6

Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery.

Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Cheng DK, et al. Among authors: jackevicius ca. Can J Cardiol. 2004 Feb;20(2):223-8. Can J Cardiol. 2004. PMID: 15010747 Review.

7

Population rates of hospitalization for atrial fibrillation/flutter in Canada.

Humphries KH, Jackevicius C, Gong Y, Svensen L, Cox J, Tu JV, Laupacis A; Canadian Cardiovascular Outcomes Research Team. Humphries KH, et al. Among authors: jackevicius c. Can J Cardiol. 2004 Jul;20(9):869-76. Can J Cardiol. 2004. PMID: 15266356

8

Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry.

Jackevicius CA, Pinto R, Daly P, Mackie K, Dzavik V. Jackevicius CA, et al. Can J Cardiol. 2005 Jan;21(1):27-32. Can J Cardiol. 2005. PMID: 15685299

9

Acute treatment of myocardial infarction in Canada 1999-2002.

Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV; Canadian Cardiovascular Outcomes Research Team. Jackevicius CA, et al. Can J Cardiol. 2005 Feb;21(2):145-52. Can J Cardiol. 2005. PMID: 15729413

10

The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention.

Ma JM, Jackevicius CA, Genus U, Dzavik V. Ma JM, et al. Can J Cardiol. 2006 Apr;22(5):419-23. doi: 10.1016/s0828-282x(06)70928-x. Can J Cardiol. 2006. PMID: 16639478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page